DirectActing Antivirals Cut Mortality and Cancer Risks in Chronic Hepatitis C

Direct-Acting Antivirals Cut Mortality and Cancer Risks in Chronic Hepatitis C

Direct-acting antiviral treatment for chronic hepatitis C virus (HCV) infection is associated with reduced risks for mortality and hepatocellular carcinoma, according to an industry...

More From BioPortfolio on "Direct-Acting Antivirals Cut Mortality and Cancer Risks in Chronic Hepatitis C"